呼吸机510(K)网络中的谓词数据可用性

Abby Bratton, Mercy Chado, Austin Davis, Julia Vaillancourt, S. Rothenberg, E. Leo
{"title":"呼吸机510(K)网络中的谓词数据可用性","authors":"Abby Bratton, Mercy Chado, Austin Davis, Julia Vaillancourt, S. Rothenberg, E. Leo","doi":"10.38126/jspg220104","DOIUrl":null,"url":null,"abstract":"Past research has substantiated concerns over transparency in medical device clearance and approval by the Food and Drug Administration (FDA), including a lack of publicly available data. Transparency in this process is necessary for patients and researchers to understand why products are granted or denied clearance for public use, allowing them to make informed decisions ranging from the innovation of future products to personal healthcare judgements. This insight is important for the premarket notification process known as the “510(k) pathway,” the regulatory process through which most medical devices are cleared for commercial distribution in the United States. This process relies on demonstrations that a new product is substantially equivalent to an existing product on the market, referred to as a predicate device. \n\nOne metric of transparency of the 510(k) pathway is the public availability of 510(k) submission summaries and the data they contain on substantially equivalent predicate devices. We analyze predicate data availability for medical ventilation devices cleared through the 510(k) pathway across a range of time intervals and product codes using one-way analysis of variance testing and Tukey’s method of multiple comparison. Out of all cleared medical ventilation devices whose submissions were received from January 1990 through October 2020, 65.64% list publicly available predicate information, primarily through summary documents in the FDA 510(k) Premarket Notification database. There is a statistically significant increase in the percentage of device submissions with available predicate data over time, with predicate data available for 93.17% of all devices submitted in the fifteen-year-period between the beginning of 2005 and the end of 2019.","PeriodicalId":222224,"journal":{"name":"Journal of Science Policy & Governance","volume":"4 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Predicate Data Availability in the Ventilator 510(K) Network\",\"authors\":\"Abby Bratton, Mercy Chado, Austin Davis, Julia Vaillancourt, S. Rothenberg, E. Leo\",\"doi\":\"10.38126/jspg220104\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Past research has substantiated concerns over transparency in medical device clearance and approval by the Food and Drug Administration (FDA), including a lack of publicly available data. Transparency in this process is necessary for patients and researchers to understand why products are granted or denied clearance for public use, allowing them to make informed decisions ranging from the innovation of future products to personal healthcare judgements. This insight is important for the premarket notification process known as the “510(k) pathway,” the regulatory process through which most medical devices are cleared for commercial distribution in the United States. This process relies on demonstrations that a new product is substantially equivalent to an existing product on the market, referred to as a predicate device. \\n\\nOne metric of transparency of the 510(k) pathway is the public availability of 510(k) submission summaries and the data they contain on substantially equivalent predicate devices. We analyze predicate data availability for medical ventilation devices cleared through the 510(k) pathway across a range of time intervals and product codes using one-way analysis of variance testing and Tukey’s method of multiple comparison. Out of all cleared medical ventilation devices whose submissions were received from January 1990 through October 2020, 65.64% list publicly available predicate information, primarily through summary documents in the FDA 510(k) Premarket Notification database. There is a statistically significant increase in the percentage of device submissions with available predicate data over time, with predicate data available for 93.17% of all devices submitted in the fifteen-year-period between the beginning of 2005 and the end of 2019.\",\"PeriodicalId\":222224,\"journal\":{\"name\":\"Journal of Science Policy & Governance\",\"volume\":\"4 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Science Policy & Governance\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.38126/jspg220104\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Science Policy & Governance","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.38126/jspg220104","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

过去的研究证实了对食品和药物管理局(FDA)医疗器械许可和批准透明度的担忧,包括缺乏公开可用的数据。这一过程的透明度对于患者和研究人员了解产品被批准或拒绝公开使用的原因是必要的,从而使他们能够做出明智的决定,从未来产品的创新到个人医疗保健判断。这一见解对于上市前通知程序(称为“510(k)途径”)非常重要,大多数医疗器械通过该监管程序获准在美国进行商业分销。该过程依赖于证明新产品实质上等同于市场上的现有产品,称为谓词设备。510(k)途径透明度的一个指标是510(k)提交摘要的公开可用性及其在实质上等同的谓词设备上包含的数据。我们分析了通过510(k)途径在一系列时间间隔和产品代码中清除的医疗通气设备的谓词数据可用性,使用单向方差检验分析和Tukey的多重比较方法。在1990年1月至2020年10月期间收到的所有已批准的医疗通气设备中,65.64%列出了公开可用的谓词信息,主要通过FDA 510(k)上市前通知数据库中的摘要文件。随着时间的推移,具有可用谓词数据的设备提交的百分比在统计上显着增加,在2005年初至2019年底的15年期间,所有提交的设备中有93.17%的谓词数据可用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Predicate Data Availability in the Ventilator 510(K) Network
Past research has substantiated concerns over transparency in medical device clearance and approval by the Food and Drug Administration (FDA), including a lack of publicly available data. Transparency in this process is necessary for patients and researchers to understand why products are granted or denied clearance for public use, allowing them to make informed decisions ranging from the innovation of future products to personal healthcare judgements. This insight is important for the premarket notification process known as the “510(k) pathway,” the regulatory process through which most medical devices are cleared for commercial distribution in the United States. This process relies on demonstrations that a new product is substantially equivalent to an existing product on the market, referred to as a predicate device. One metric of transparency of the 510(k) pathway is the public availability of 510(k) submission summaries and the data they contain on substantially equivalent predicate devices. We analyze predicate data availability for medical ventilation devices cleared through the 510(k) pathway across a range of time intervals and product codes using one-way analysis of variance testing and Tukey’s method of multiple comparison. Out of all cleared medical ventilation devices whose submissions were received from January 1990 through October 2020, 65.64% list publicly available predicate information, primarily through summary documents in the FDA 510(k) Premarket Notification database. There is a statistically significant increase in the percentage of device submissions with available predicate data over time, with predicate data available for 93.17% of all devices submitted in the fifteen-year-period between the beginning of 2005 and the end of 2019.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Cover Memo: Volume 23, Issue 2, Special Issue on Civic Science for Transformative Policy Solutions to Societal Challenges Left out of the Room Where it Happens: Barriers to Serving in Senior Congressional Staff Roles May Limit “Representative” Science Policymaking Community-Driven Civic Science: Relationship Building to Prioritize Public Needs Rethinking Civic Science Funding to Better Support Community Engagement From Intent to Impact: Enabling Transdisciplinary Research for Responsible Scientific Stewardship
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1